Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chimerism

• Publication date

  2014-10-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/19381956.2015.1103423PMID 26650878PMCID PMC5063086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.

  2014cited by this paper
• Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications.

  2014cited by this paper
• Research Highlights and Editors’ Picks

  2013cited by this paper
• Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

  2013cited by this paper
• Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

  2012cited by this paper
• Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.

  2012cited by this paper
• Emerging concepts in haematopoietic cell transplantation

  2012cited by this paper
• Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model

  2012cited by this paper
• Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells

  2011cited by this paper
• Pregnancy, Microchimerism, and the Maternal Grandmother

  2011cited by this paper
• Clinical tolerance in allogeneic hematopoietic stem cell transplantation

  2011cited by this paper
• Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.

  2011cited by this paper
• Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies

  2011cited by this paper
• T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients

  2011cited by this paper
• Hematopoietic stem cell transplantation for thalassemia.

  2011cited by this paper
• Faculty Opinions recommendation of Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

  2011cited by this paper
• Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.

  2010cited by this paper
• Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease

  2010cited by this paper
• Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia

  2009cited by this paper
• Loss of mismatched HLA in leukemia after stem-cell transplantation.

  2009cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2008cited by this paper
• Stable Multilineage Chimerism without Graft versus Host Disease Following Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation

  2006cited by this paper
• Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia.

  2004cited by this paper
• Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

  1999cited by this paper
• High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells

  1994cited by this paper

• Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance

  2026cites this paper
• Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation

  2024cites this paper
• Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation

  2024cites this paper
• Tr1 Cells as a Key Regulator for Maintaining Immune Homeostasis in Transplantation

  2021influential citation
• Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

  2021cites this paper
• The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application

  2021cites this paper
• Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.

  2020cites this paper
• Evolution of the role of haploidentical stem cell transplantation: past, present, and future

  2020cites this paper
• Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion‐dependent pediatric thalassemia patients

  2020cites this paper
• Stem cell therapy for thalassemia: present and future

  2018cites this paper
• Function of T regulatory type 1 cells is down-regulated and is associated with the clinical presentation of coronary artery disease.

  2018cites this paper
• The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases.

  2018cites this paper
• Molecular and functional heterogeneity of IL-10-producing CD4+ T cells

  2018cites this paper
• The study of engraftment after hematopoietic stem cell transplantation: From the presence of mixed chimerism to the development of immunological tolerance

  2018cites this paper
• Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide

  2018cites this paper
• Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy

  2017cites this paper
• Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.

  2017cites this paper